European Journal of Biomedical and Pharmaceutical Sciences

CLINICAL STUDY ON “DHAMA” (BRONCHIAL ASTHMA) AND EVALUATION OF A UNANI FORMULATION IN ITS TREATMENT

Naseer Ahmad Hakeem*, Haider Ali Quraishi, Rehana Yousuf, Saleem-ur-Rehman, Majid-ul-Majid and M. Y. Dinthoo

ABSTRACT

Asthma and chronic obstructive pulmonary disease (COPD) are among the top ten most common diseases worldwide causing significant social and economic burden on the patient, family and health system. Despite the availability of safe and effective respiratory medication, problems such as under diagnosis, medication, adherence issue and poor understanding of asthma and COPD have led to the condition being poorly managed worldwide. The different organs in the body needs a constant supply of oxygen to produce energy to grow, repair or replace itself and maintain vital functions. The oxygen must be provided to the cells in a way that they are able to use it. It must be brought into the body as air that is cleaned, cooled or heated, humidified, and delivered in the right amounts. In this research efficacy of Unani formulation (test drug) has been evaluated on the basis of standard parameters. The efficacy of the test drug was compared with the standard drug ‗Ambroxol‘. The evaluation of the efficacy was based on subjective parameters like cough, sputum production and breathlessness and objective parameters.

Keywords: Asthma, Dhama, COPD, Unani Medicine.